FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1046 September 30, 1993 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Figueroa, M.

To the Editor: Dr. Figueroa et al. (April 29 issue)¹ demonstrated that combination chemotherapy is beneficial to some patients in whom immune thrombocytopenic purpura is refractory to corticosteroids and splenectomy. Since all 10 patients had had splenectomies, were studies performed to exclude the possibility of accessory spleens before combination chemotherapy was given? Accessory spleens are common among middle-aged and older adults and are found in about 20 percent of autopsy cases^2,3. They have been associated with recurrent immune thrombocytopenic purpura^3,4. Among patients from whom accessory spleens have been removed, remission rates have ranged from 27 to 80 percent^3,4. . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.